FORX-428

FoRx Therapeutics AG · Phase 1 active Small molecule

At a glance

Generic name	FORX-428
Sponsor	FoRx Therapeutics AG
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FORX-428 CI brief — competitive landscape report
FORX-428 updates RSS · CI watch RSS
FoRx Therapeutics AG portfolio CI